PTEN and neoplasm: A large variety of oncogenes and tumor suppressors (e.g. MYC, KRAS, HIF-1α stabilization, mTOR, P53, PTEN etc.)have been found to influence the glutamine metabolism and its effector pathways, emphasizing the importance of the glutamine pathway in tumor cell development, expansion and metastatic properties (113).